The third wave of corona infection will not have much effect on children. The World Health Organization (WHO) and the All India Institute of Medical Sciences (AIIMS) have claimed this in their seroprevalence survey. Because of the dangerous variant of Corona, fears of a third wave are being expressed in India, but now the claim of WHO and AIIMS in a new study is going to give relief.
According to the survey, the SARS-CoV-2 seropositivity rate is higher in children than in adults. Seropositivity refers to the physical ability to mount a natural immune response to the virus. Puneet Mishra, Professor of Community Medicine at Delhi AIIMS, said that seroprevalence was found to be very high at 74.7% in the refugee colonies of South Delhi.
This figure is the highest in any serosurvey conducted so far. According to the survey, even before the second wave, seroprevalence among children below 18 years living in south Delhi was 73.9%. More seroprevalence will act as a shield for children against the third wave.
10 thousand samples were taken from five states
For this survey, 10 thousand samples were taken from 5 states. At present, in the report that has come, 4500 samples from 4 states have been made the basis. In the next two three months, the complete report of 10 thousand sample sizes of the five states will come.
The mean ages for the study sites in Delhi Urban, Delhi Rural, Bhubaneswar, Gorakhpur, and Agartala were 11 years, 12 years, 11 years, 13 years, and 14 years. The data for the study was collected between 15 March 2021 and 10 June 2021. The ELISA kit was used to assess total serum antibodies against SARS-CoV-2, according to the researchers. This kit will detect the presence of antibodies to the coronavirus in the human body.
Sputnik V to bring booster shot against Delta variant
Here, the Russian vaccine Sputnik V has said that it will soon provide a booster shot. This booster dose will prove to be effective on the first Delta variant of the Coronavirus found in India. Along with this, the company has said that it will soon work with other vaccine manufacturers in the war against Corona.
Let us tell you that Sputnik V is the world's first corona vaccine, which was made by Russia's Gamalya Research Center last year. Sputnik V is the third vaccine to be used in India after Coveshield and Covaxin. It is being prepared by Hyderabad-based pharma company Dr. Reddy in collaboration with a Russian company.
Phase III data not given to WHO: Bharat Biotech
The country's leading vaccine maker Bharat Biotech has denied reports of Covaxin's Phase III data being submitted to the World Health Organization (WHO). The company said on Thursday that such reports are wrong that the company has given data of the third phase of the Covaxin vaccine to the WHO.
The world is deeply concerned about the new variant of Corona 'Omicron'. The European Union hasti
Yudh Abhyas 2022: Indo-US military exercise near Barahoti, why is this area special?
These days a joint military exercise is going on between India and America in Auli, Uttarakhand.
Former international umpire Anil Chaudhary has claimed that the recent controversy surrounding th
'Operation Sindoor is going on...', Rajnath Singh reveals; 100 terrorists killed in India's action.
Defence Minister Rajnath Singh said in the all-party meeting that at least 100 terrorists were ki
Given the severe pollution and health emergency-like situation in Delhi, the Delhi government has
India-Canada: Khalistan supporters demonstrated in Vancouver, security increased at Indian Consulate
The tension between Canada and India is not slowing down. Both countries have expelled each other
The government's earnings in the form of GST increased by 11 percent year-on-year in November on
The havoc of rain has been seen in Thane city of Maharashtra. Life came to a standstill on Saturd
This production house will make a web series on Tata Group, who will play the role of Ratan Tata?
The Tata Group is counted among the most successful and powerful business groups in India. Millio
In early trade on Friday, the Indian rupee has slipped to the lowest level of Rs 79.11 against th
